Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NS8T
|
||||
| Former ID |
DIB009018
|
||||
| Drug Name |
13-DEOXYADRIAMYCIN HYDROCHLORIDE
|
||||
| Synonyms |
GPX-100; (8R,10S)-10-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyethyl)-1-methoxynaphthacene-5,12-dione hydrochloride; 13-Deoxydoxorubicin hydrochloride
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [521653] | ||
| Company |
Access Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | [1572591] | |
| DNA topoisomerase II | Target Info | Modulator | [1572591] | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.